Charles Irving

Charles Irving has a PhD in Chemistry from Weizmann Institute of Science and a Bachelor of Arts in Chemistry from Wesleyan University. With a background in chemistry, Charles has held various roles at Cell Cure Neurosciences Ltd., including Advisor and Chief Executive Officer. At Phythera Therapeutics, Inc., Charles has served as Vice President of Business Development, Senior Vice President of Business Development, and currently holds the position of Chief Development Officer, where Charles focuses on cancer drug development.